Enforcement node and legal consequences: RF therapy devices and RF skin therapy devices have been formally managed as Class III medical devices since April 1, 2026.
Products without a medical device registration certificate may not be produced, imported, or sold.
Management category: Class III; classification code 09-07-02.
The basis traces to the NMPA’s March 2022 announcement on adjusting part of the Medical Device Classification Catalogue, after a two-year transition period.
Definition boundary of “RF beauty equipment”: according to the RF Beauty Equipment Registration Review Guidelines, RF beauty equipment refers to products that “use RF current at specific frequencies (usually above 200 kHz) or electric fields (usually 13.56 or 40.68 MHz) or other electrical energy to act on human tissue and produce thermal effects, to treat skin laxity, reduce skin wrinkles, shrink pores, tighten/lift skin tissue, or treat acne, scars, or reduce fat”.
The definition explicitly covers both floor-standing/desktop large equipment and handheld small equipment; home RF devices have no room to be managed as home appliances “because they are small”.
Clinical evaluation: no exemption, no shortcuts.
The Guidelines explicitly state that RF beauty equipment is not in the catalogue exempt from clinical evaluation and should follow the clinical evaluation recommended pathway for Category 09 “physical therapy devices” in the Medical Device Classification Catalogue.
The 2026 enforcement position further confirms: no downgraded filing, no clinical exemption, no filing shortcut; RF therapy device Class III certificates require prospective clinical trials.
The materials chain companies must prepare includes registration testing (electrical safety, EMC, etc.), clinical evaluation data, and quality system inspection; timelines are measured in quarters, and a single test report is no longer enough to list.
Scope and contraindication labeling requirements: RF beauty devices must specify the intended application sites and uses in the scope of application; for special areas such as eyes, cheeks, and neck, usable and prohibited areas must be clearly indicated in图示 form. This means “eye-safe” cannot rely on textual implication; it must have a graphical boundary statement.
Imported products not managed as medical devices in the country of origin must also provide the corresponding regulatory basis and proof of permission to sell in the country of origin.
Direct implication for eye-related RF products: if a product claims to act on periorbital skin with RF energy for wrinkle reduction/tightening, it falls under the Class III medical device registration pathway, not the eye massager group standard pathway.
“Eye-safe” in this framework is a graphical boundary in the registration certificate’s scope, not a marketing sentence.